Compare GSK plc (GSK) vs Uber Technologies Inc (UBER) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Uber Technologies Inc — how do they compare? GSK plc trades at $52.67 (market cap $101.34B), while Uber Technologies Inc trades at $73.55 (market cap $147.93B). The key difference: Uber Technologies Inc is the larger of the two by market cap, and GSK plc pays a 3.49% dividend while Uber Technologies Inc pays none. Which is the better fit depends on your goals.
| GSK | UBER | |
|---|---|---|
Market Cap | $101.34B | $147.93B |
Sector | Health | Industrials |
52-Week High | $61.18 | $100.10 |
52-Week Low | $36.20 | $68.61 |
Enterprise Value | $121.95B | $154.25B |
Dividend Yield | 3.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $52.64, up 2.7% on the day, with a bearish technical signal despite recent earnings beats. The company reported Q1 2026 EPS of $1.24, beating estimates of $1.16, and maintains strong profitability with a 17.78% net income margin. Positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline strength, while a pending acquisition of Nuvalent, Inc. signals strategic expansion.
GSK offers value with a P/E of 13.71 and stable cash flows, but faces risks from clinical setbacks, as seen in the terminated Alector partnership. Analyst sentiment is mixed with 31% buy ratings, reflecting cautious optimism amid competitive and regulatory pressures. The stock's outlook hinges on execution of growth initiatives and pipeline developments.
Uber Technologies (UBER) trades at $72.08, down 2.94% today, amid bearish technical signals despite strong fundamentals. The company reported robust 2025 results with $52.02B revenue and $10.05B net income, though 2026 projections show moderating growth. Recent news highlights strategic shifts toward autonomous vehicles with robotaxi pilots in Madrid and Munich, alongside cost-cutting measures including HR layoffs. Analyst consensus remains strongly bullish with an $108.92 price target, representing 51% upside potential from current levels.
Uber presents a compelling growth story with expanding profitability and market dominance, though near-term technical weakness and moderating 2026 earnings projections warrant caution. The autonomous vehicle expansion represents significant long-term opportunity, while competitive pressures and regulatory risks persist. With zero sell ratings and overwhelming analyst support, the stock appears fundamentally undervalued despite current bearish technical indicators.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Uber Technologies Inc
Uber Technologies is a technology provider that matches riders with drivers, hungry people with restaurants and food delivery service providers, and shippers with carriers. The firm's on-demand technology platform could eventually be used for additional products and services, such as autonomous vehicles, delivery via drones, and Uber Elevate, which, as the firm refers to it, provides aerial ride-sharing. Uber Technologies is headquartered in San Francisco and operates in over 63 countries with over 110 million users that order rides or foods at least once a month. Approximately 76% of its gross revenue comes from ride-sharing and 22% from food delivery.
Read more on UBER →
